More than a fifth go private as access to NHS treatment tightens
More than 20% of people in the UK have accessed private healthcare because they couldn't get the treatment they required on the NHS, according...
Private dentists on brink of collapse as routine treatment suspended
Many private dental providers are just weeks away from collapse following the suspension of routine treatment in the wake of the Covid-19 outbreak.
The British...
Create profits soar despite pause on treatments
Create Health Ltd, the fertility treatment and IVF provider acquired by Spanish Group IVI RMA Global last year, has reported a 30% jump in...
New Fund aims to boost digital adoption in health and social care
West Midlands Academic Health Science Network (WMAHSN) and Mercia Asset Management (MAM) have opened a new SME Innovation Fund for businesses developing digital solutions...
Aviva extends ‘guided hospital option’ to individual and SME policies
Aviva has introduced a new ‘guided hospital option’ to help direct its SME and individual customers to the most appropriate hospital and book their...
St Andrew’s announces plans to scale back CAMHS provision
St Andrew’s Healthcare (STAH) today announced plans to dramatically scale back its child and adolescent mental health services (CAMHS) concerns raised by the CQC.
The...
EBITDAR down but Ramsay reports positive signs on price and volumes
Ramsay Healthcare has reported a 1.6% rise in its UK revenue to £209.6m for the six months ended 31 December 2018.
The Australian-owned company said...
NHS unable to cope with growing demand for cancer and elective care
The NHS’s inability to keep up with growing demand is driving down performance against waiting times standards for elective and cancer care, according to...
Vita Health boosted by contract wins
Mental health and musculoskeletal specialist Vita Health Group has reported a 48% leap in revenue to £18.8m as investment in new businesses and contract...
Palatine completes sale of Veincentre to CBPE
Mid-market private equity firm Palatine has completed its sale of Veincentre to CBPE Capital (CBPE).
Financial details of the transaction have not been disclosed.
Palatine backed...
©2024 All rights reserved LaingBuisson 